Popular Hemp

United States Medical Cannabis Product State-by-State Regulatory Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US Medical Cannabis Products: A State-by-State Regulatory Report” report has been added to ResearchAndMarkets.com’s offering.

This report analyses the different approaches taken by states over what restrictions they impose on medical cannabis products that patients can buy.

The growing number of states, including some of the most conservative ones, that have legalized medical cannabis programs demonstrates the increased popular support for medical cannabis and its potential benefits.

However, not all medical cannabis programs are created equal. Many states allow patients to access a full panoply of medical cannabis products with no limit on THC concentration, while others prohibit certain product types and cap the amount of THC that products may contain.

Key Topics Covered:

1 Executive Summary

2 Introduction

3 Legality Of Medical Cannabis By State

4 Legality Of Medical Cannabis

5 Medical Cannabis Product Restrictions By State

6 Medical Cannabis Product Restrictions

7 State-By-State Analysis

For more information about this report visit https://www.researchandmarkets.com/r/k3rzfc

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

This post was originally published on this site

0 thoughts on “United States Medical Cannabis Product State-by-State Regulatory Report 2022 – ResearchAndMarkets.com”

Write a Reply or Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.